281 results
Page 5 of 15
8-K
EX-99.1
kyyvoo22xb
13 Apr 20
Alimera Sciences Pre-Announces Expected Top Line Revenue for Q1 2020 and Provides COVID-19 Business Update
5:12pm
8-K
1kp1ff4m
13 Apr 20
Alimera Sciences Pre-Announces Expected Top Line Revenue for Q1 2020 and Provides COVID-19 Business Update
5:12pm
8-K
EX-10.65
3bc42dgytahtk8w2c
6 Jan 20
Entry into a Material Definitive Agreement
8:25am
8-K
0jrx40csmrp
14 Nov 19
Alimera Sciences Announces Effectiveness
5:02pm
8-K
EX-99.1
cqgkgq6r
8 Nov 19
Alimera Sciences Announces Board’s Approval of Reverse Stock Split Ratio
12:00am
8-K
EX-10.64
9mj pm9ww
25 Oct 19
Alimera Sciences Announces Equity Purchase Agreement for up to
9:00am
8-K
0hjvesh2chkn
19 Jul 19
Alimera Sciences Announces the Appointment of Industry Veteran and Ophthalmology Business Executive John Snisarenko to its Board of Directors
9:03am
8-K
EX-10.62
ixwn l7nrbxs
19 Jul 19
Alimera Sciences Announces the Appointment of Industry Veteran and Ophthalmology Business Executive John Snisarenko to its Board of Directors
9:03am
S-8
2v2th
20 Jun 19
Registration of securities for employees
12:00am
8-K
EX-10.61
p7pit0f
19 Jun 19
Departure of Directors or Certain Officers
5:21pm
8-K
EX-10.60
p18q4j9cv71raadaml
19 Jun 19
Departure of Directors or Certain Officers
5:21pm
8-K
EX-10.59
acrdksg4
8 May 19
Departure of Directors or Certain Officers
4:32pm
8-K
y6qb0
8 May 19
Departure of Directors or Certain Officers
4:32pm
8-K
EX-10.58
bte99 usmeao
8 May 19
Departure of Directors or Certain Officers
4:32pm